Cargando…
CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations
Heterogeneity of bone marrow mesenchymal stromal cells (MSCs, frequently referred to as “mesenchymal stem cells”) clouds biological understanding and hampers their clinical development. In MSC cultures most commonly used in research and therapy, we have identified an MSC subtype characterized by CD3...
Autores principales: | Kay, Alasdair G., Fox, James M., Hewitson, James P., Stone, Andrew P., Robertson, Sophie, James, Sally, Wang, Xiao-nong, Kapasa, Elizabeth, Yang, Xuebin B., Genever, Paul G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207511/ https://www.ncbi.nlm.nih.gov/pubmed/35734183 http://dx.doi.org/10.3389/fimmu.2022.903796 |
Ejemplares similares
-
Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations
por: Kay, Alasdair G., et al.
Publicado: (2022) -
Biomolecular phenotyping and heterogeneity assessment of mesenchymal stromal cells using label-free Raman spectroscopy
por: Rocha, R. A., et al.
Publicado: (2021) -
Characterisation of mesenchymal stromal cells in clinical trial reports: analysis of published descriptors
por: Wilson, Alison J., et al.
Publicado: (2021) -
Multiplicity of Mesenchymal Stromal Cells: Finding the Right Route to Therapy
por: Wilson, Alison, et al.
Publicado: (2019) -
Attitudes Towards Standardization of Mesenchymal Stromal Cells—A Qualitative Exploration of Expert Views
por: Wilson, Alison J, et al.
Publicado: (2023)